BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 8419649)

  • 1. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
    Broder CC; Berger EA
    J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
    Berger EA; Lifson JD; Eiden LE
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A region in domain 1 of CD4 distinct from the primary gp120 binding site is involved in HIV infection and virus-mediated fusion.
    Truneh A; Buck D; Cassatt DR; Juszczak R; Kassis S; Ryu SE; Healey D; Sweet R; Sattentau Q
    J Biol Chem; 1991 Mar; 266(9):5942-8. PubMed ID: 1706342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.
    Berger EA; Sisler JR; Earl PL
    J Virol; 1992 Oct; 66(10):6208-12. PubMed ID: 1527858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.
    Golding H; Blumenthal R; Manischewitz J; Littman DR; Dimitrov DS
    J Virol; 1993 Nov; 67(11):6469-75. PubMed ID: 8411350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.
    Andeweg AC; Leeflang P; Osterhaus AD; Bosch ML
    J Virol; 1993 Jun; 67(6):3232-9. PubMed ID: 7684463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.
    Dimitrov DS; Broder CC; Berger EA; Blumenthal R
    J Virol; 1993 Mar; 67(3):1647-52. PubMed ID: 8437234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
    Das R; Datta R; Varadarajan R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events.
    Thali M; Furman C; Helseth E; Repke H; Sodroski J
    J Virol; 1992 Sep; 66(9):5516-24. PubMed ID: 1501286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemically induced CD4 mutants of a human T cell line. Evidence for dissociation between binding of HIV I envelope and susceptibility to HIV I infection and syncytia formation.
    Hillman K; Shapira-Nahor O; Gruber MF; Hooley J; Manischewitz J; Seeman R; Vujcic L; Geyer SJ; Golding H
    J Immunol; 1990 Mar; 144(6):2131-9. PubMed ID: 1690235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion from without directed by human immunodeficiency virus particles.
    Clavel F; Charneau P
    J Virol; 1994 Feb; 68(2):1179-85. PubMed ID: 8289347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 2 envelope glycoprotein: differential CD4 interactions of soluble gp120 versus the assembled envelope complex.
    Mulligan MJ; Ritter GD; Chaikin MA; Yamshchikov GV; Kumar P; Hahn BH; Sweet RW; Compans RW
    Virology; 1992 Mar; 187(1):233-41. PubMed ID: 1736526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple effects of CD4 CDR3-related peptide derivatives showing anti-HIV-1 activity on HIV-1 gp120 functions.
    Ohki K; Kimura T; Jones IM; Morita F; Ikuta K
    Vaccine; 1994 Mar; 12(4):343-50. PubMed ID: 8178557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
    Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
    J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the D strand of the human CD4 V1 domain affect CD4 interactions with the human immunodeficiency virus envelope glycoprotein gp120 and HLA class II antigens similarly.
    Piatier-Tonneau D; Gastinel LN; Moussy G; BĂ©nichou B; Amblard F; Vaigot P; Auffray C
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6858-62. PubMed ID: 1713692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).
    Broder CC; Dimitrov DS; Blumenthal R; Berger EA
    Virology; 1993 Mar; 193(1):483-91. PubMed ID: 8438583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.
    Ashorn PA; Berger EA; Moss B
    J Virol; 1990 May; 64(5):2149-56. PubMed ID: 2109100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1.
    Roben P; Moore JP; Thali M; Sodroski J; Barbas CF; Burton DR
    J Virol; 1994 Aug; 68(8):4821-8. PubMed ID: 7518527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.